Lifecore Biomedical
(NASDAQ:LFCR)
$6.69
0.375[5.94%]
At close: Apr 19
$6.69
0[0.00%]
After Hours: 4:00PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
2.4
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Lifecore Biomedical Inc
Sector
Health Care
Industry
Life Sciences Tools & Services
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (C...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LFCR
HBIO

FAQ

Q

How do I buy Lifecore Biomedical (LFCR) stock?

A

You can purchase shares of Lifecore Biomedical (NASDAQ: LFCR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lifecore Biomedical's (LFCR) competitors?

Q

What is the target price for Lifecore Biomedical (LFCR) stock?

A

The latest price target for Lifecore Biomedical (NASDAQ: LFCR) was reported by Barrington Research on Friday, September 1, 2023. The analyst firm set a price target for 10.00 expecting LFCR to rise to within 12 months (a possible 49.48% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lifecore Biomedical (LFCR)?

A

The stock price for Lifecore Biomedical (NASDAQ: LFCR) is $6.69 last updated April 19, 2024 at 4:00 PM EDT.

Q

Does Lifecore Biomedical (LFCR) pay a dividend?

A

There are no upcoming dividends for Lifecore Biomedical.

Q

When is Lifecore Biomedical (NASDAQ:LFCR) reporting earnings?

A

Lifecore Biomedical’s Q3 earnings are confirmed for Thursday, May 30, 2024.

Q

Is Lifecore Biomedical (LFCR) going to split?

A

There is no upcoming split for Lifecore Biomedical.

Q

What sector and industry does Lifecore Biomedical (LFCR) operate in?

A

Lifecore Biomedical is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch